Mondelez International Toekomstige groei
Future criteriumcontroles 1/6
Mondelez International zal naar verwachting groeien in winst en omzet met respectievelijk 10.6% en 4.4% per jaar. De winst per aandeel zal naar verwachting groeien met 10.8% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 17.9% zijn.
Belangrijke informatie
10.6%
Groei van de winst
10.8%
Groei van de winst per aandeel
| Food winstgroei | 14.0% |
| Inkomstengroei | 4.4% |
| Toekomstig rendement op eigen vermogen | 17.9% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 06 Nov 2024 |
Recente toekomstige groei-updates
Results: Mondelez International, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
May 03
Analysts Have Made A Financial Statement On Mondelez International, Inc.'s (NASDAQ:MDLZ) Annual Report
Feb 01Recent updates
Mondelez: Sales Volumes Return To Growth, But Continuity Is Needed
Oct 31Mondelez International, Inc.'s (NASDAQ:MDLZ) Intrinsic Value Is Potentially 90% Above Its Share Price
Oct 25Mondelez International: Is It Time To Buy The Snacking Firm
Sep 22Mondelez: Overrated Idea In A Highly Competitive Segment
Sep 05Mondelez International (NASDAQ:MDLZ) Seems To Use Debt Quite Sensibly
Aug 17There's Been No Shortage Of Growth Recently For Mondelez International's (NASDAQ:MDLZ) Returns On Capital
Jul 29Mondelez International, Inc.'s (NASDAQ:MDLZ) Shareholders Might Be Looking For Exit
Jul 16Here's Why We Think Mondelez International (NASDAQ:MDLZ) Is Well Worth Watching
Jul 01Mondelez International: High-Quality Products And A Solid Dividend Growth Record
Jun 24Mondelez: Strike Now And Buy This High-Quality Dividend Growth Stock
Jun 06An Intrinsic Calculation For Mondelez International, Inc. (NASDAQ:MDLZ) Suggests It's 41% Undervalued
May 21Mondelez International's (NASDAQ:MDLZ) Earnings Offer More Than Meets The Eye
May 07Results: Mondelez International, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
May 03Mondelez: Undervalued & Solid Growth Potential Following Q1 Earnings
May 01Mondelez: Double-Digit Annual Total Return Potential Could Make It A Buy Now
Apr 23Is Mondelez International (NASDAQ:MDLZ) A Risky Investment?
Apr 22Some Confidence Is Lacking In Mondelez International, Inc.'s (NASDAQ:MDLZ) P/E
Apr 08We Ran A Stock Scan For Earnings Growth And Mondelez International (NASDAQ:MDLZ) Passed With Ease
Mar 25Mondelez: Gaining Market Share In Key Categories
Mar 18Mondelez: Higher Cocoa Prices To Weigh On Margins
Mar 07Mondelez International, Inc.'s (NASDAQ:MDLZ) Intrinsic Value Is Potentially 61% Above Its Share Price
Feb 14Analysts Have Made A Financial Statement On Mondelez International, Inc.'s (NASDAQ:MDLZ) Annual Report
Feb 01Mondelez: Steady Appreciation And Strong Dividend Growth
Jan 28The Return Trends At Mondelez International (NASDAQ:MDLZ) Look Promising
Jan 21I Believe Mondelez Is One Of The Best Dividend Stocks Amid Headwinds
Jan 11There's Reason For Concern Over Mondelez International, Inc.'s (NASDAQ:MDLZ) Price
Dec 28Is Mondelez International (NASDAQ:MDLZ) A Risky Investment?
Dec 04Should You Be Adding Mondelez International (NASDAQ:MDLZ) To Your Watchlist Today?
Nov 22Mondelez International, Inc. (NASDAQ:MDLZ) Shares Could Be 38% Below Their Intrinsic Value Estimate
Oct 29We Like These Underlying Return On Capital Trends At Mondelez International (NASDAQ:MDLZ)
Sep 20Mondelez International (NASDAQ:MDLZ) Has A Pretty Healthy Balance Sheet
Aug 25Here's Why We Think Mondelez International (NASDAQ:MDLZ) Is Well Worth Watching
Aug 13A Look At The Fair Value Of Mondelez International, Inc. (NASDAQ:MDLZ)
Jul 17Returns On Capital At Mondelez International (NASDAQ:MDLZ) Have Stalled
Jun 19Is Mondelez International (NASDAQ:MDLZ) A Risky Investment?
May 22Calculating The Fair Value Of Mondelez International, Inc. (NASDAQ:MDLZ)
Apr 09Mondelez International's (NASDAQ:MDLZ) Returns Have Hit A Wall
Mar 13Mondelez International (NASDAQ:MDLZ) Has A Pretty Healthy Balance Sheet
Feb 21Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 39,857 | 4,908 | 4,759 | 6,730 | 16 |
| 12/31/2025 | 38,253 | 4,465 | 4,542 | 6,448 | 23 |
| 12/31/2024 | 36,635 | 3,999 | 3,587 | 5,275 | 23 |
| 9/30/2024 | 36,151 | 3,816 | 3,701 | 5,015 | N/A |
| 6/30/2024 | 35,976 | 3,947 | 3,604 | 4,887 | N/A |
| 3/31/2024 | 36,140 | 4,290 | 3,727 | 4,915 | N/A |
| 12/31/2023 | 36,016 | 4,959 | 3,602 | 4,714 | N/A |
| 9/30/2023 | 35,397 | 4,592 | 3,477 | 4,542 | N/A |
| 6/30/2023 | 34,131 | 4,140 | 2,898 | 3,914 | N/A |
| 3/31/2023 | 32,898 | 3,943 | 2,938 | 3,900 | N/A |
| 12/31/2022 | 31,496 | 2,717 | 3,002 | 3,908 | N/A |
| 9/30/2022 | 30,459 | 3,137 | 2,990 | 3,937 | N/A |
| 6/30/2022 | 29,878 | 3,863 | 3,376 | 4,316 | N/A |
| 3/31/2022 | 29,246 | 4,194 | 3,441 | 4,357 | N/A |
| 12/31/2021 | 28,720 | 4,300 | 3,176 | 4,141 | N/A |
| 9/30/2021 | 28,360 | 4,453 | 3,497 | 4,369 | N/A |
| 6/30/2021 | 27,843 | 4,314 | 3,370 | 4,198 | N/A |
| 3/31/2021 | 27,112 | 3,780 | 3,730 | 4,595 | N/A |
| 12/31/2020 | 26,581 | 3,555 | 3,101 | 3,964 | N/A |
| 9/30/2020 | 26,196 | 3,132 | 3,529 | 4,398 | N/A |
| 6/30/2020 | 25,886 | 3,439 | 3,572 | 4,477 | N/A |
| 3/31/2020 | 26,037 | 3,698 | 2,910 | 3,784 | N/A |
| 12/31/2019 | 25,868 | 3,929 | 3,040 | 3,965 | N/A |
| 9/30/2019 | 25,728 | 4,019 | 2,974 | 3,945 | N/A |
| 6/30/2019 | 25,661 | 3,787 | 2,784 | 3,812 | N/A |
| 3/31/2019 | 25,711 | 3,302 | 2,930 | 4,006 | N/A |
| 12/31/2018 | 25,938 | 3,317 | 2,853 | 3,948 | N/A |
| 9/30/2018 | 26,131 | 3,253 | 2,578 | 3,681 | N/A |
| 6/30/2018 | 26,373 | 3,040 | N/A | 3,513 | N/A |
| 3/31/2018 | 26,247 | 3,244 | N/A | 3,557 | N/A |
| 12/31/2017 | 25,896 | 2,828 | N/A | 2,593 | N/A |
| 9/30/2017 | 25,700 | 2,226 | N/A | 2,497 | N/A |
| 6/30/2017 | 25,566 | 1,793 | N/A | 2,763 | N/A |
| 3/31/2017 | 25,882 | 1,735 | N/A | 2,735 | N/A |
| 12/31/2016 | 25,923 | 1,635 | N/A | 2,838 | N/A |
| 9/30/2016 | 26,517 | 837 | N/A | 3,454 | N/A |
| 6/30/2016 | 26,970 | 7,555 | N/A | 3,494 | N/A |
| 3/31/2016 | 28,329 | 7,497 | N/A | 3,556 | N/A |
| 12/31/2015 | 29,636 | 7,267 | N/A | 3,728 | N/A |
| 9/30/2015 | 31,102 | 8,496 | N/A | 3,825 | N/A |
| 6/30/2015 | 32,590 | 2,129 | N/A | 3,765 | N/A |
| 3/31/2015 | 33,365 | 2,345 | N/A | 3,857 | N/A |
| 12/31/2014 | 34,244 | 2,184 | N/A | 3,562 | N/A |
| 9/30/2014 | 34,902 | 1,847 | N/A | 6,361 | N/A |
| 6/30/2014 | 35,037 | 1,960 | N/A | 6,360 | N/A |
| 3/31/2014 | 35,196 | 1,939 | N/A | 6,218 | N/A |
| 12/31/2013 | 35,299 | 2,312 | N/A | 6,410 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei MDLZ ( 10.6% per jaar) ligt boven de spaarquote ( 2.6% ).
Winst versus markt: De winst van MDLZ ( 10.6% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 15.6% per jaar).
Hoge groeiwinsten: De winst van MDLZ zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van MDLZ ( 4.4% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 8.9% per jaar).
Hoge groei-inkomsten: De omzet van MDLZ ( 4.4% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen MDLZ zal naar verwachting over 3 jaar laag zijn ( 17.9 %).